These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8294839)

  • 1. The presence of myofibroblasts in the dermis of patients with Dupuytren's contracture. A possible source for recurrence.
    McCann BG; Logan A; Belcher H; Warn A; Warn RM
    J Hand Surg Br; 1993 Oct; 18(5):656-61. PubMed ID: 8294839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.
    Verjee LS; Midwood K; Davidson D; Essex D; Sandison A; Nanchahal J
    J Hand Surg Am; 2009 Dec; 34(10):1785-94. PubMed ID: 19910144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin involvement in Dupuytren's disease.
    Wade R; Igali L; Figus A
    J Hand Surg Eur Vol; 2016 Jul; 41(6):600-8. PubMed ID: 26353945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture.
    Hindman HB; Marty-Roix R; Tang JB; Jupiter JB; Simmons BP; Spector M
    J Bone Joint Surg Br; 2003 Apr; 85(3):448-55. PubMed ID: 12729127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hueston revisited: use of acellular dermal matrix following fasciectomy for the treatment of Dupuytren's disease.
    Terry MJ; Sue GR; Goldberg C; Narayan D
    Ann Plast Surg; 2014 Dec; 73 Suppl 2():S178-80. PubMed ID: 24691328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular actin as a marker for myofibroblasts in vitro.
    Foo IT; Naylor IL; Timmons MJ; Trejdosiewicz LK
    Lab Invest; 1992 Dec; 67(6):727-33. PubMed ID: 1460863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
    Pagnotta A; Specchia N; Soccetti A; Manzotti S; Greco F
    J Hand Surg Am; 2003 Nov; 28(6):1029-34. PubMed ID: 14642522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
    J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1.
    Bisson MA; McGrouther DA; Mudera V; Grobbelaar AO
    J Hand Surg Br; 2003 Aug; 28(4):351-6. PubMed ID: 12849947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue.
    Tomasek JJ; Haaksma CJ
    Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histogenesis of Dupuytren's disease: an immunohistochemical study of 30 cases.
    Shum DT; McFarlane RM
    J Hand Surg Am; 1988 Jan; 13(1):61-7. PubMed ID: 3351230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.